To the best of our knowledge, our results clarified for the first time the relationship between sarcopenia and IP-10 levels in patients with primary HCC, and our data may aid in the identification of those patients at a high-risk of developing sarcopenia and contribute to the development of therapeutic intervention methods. This evidence concerns the gene CXCL10 and hepatocellular carcinoma.